Levodopa-Induced Motor and Dopamine Receptor Changes in Caenorhabditis elegans Overexpressing Human Alpha-Synuclein
Authors:
- Deepak K. GuptaDGDeepak K. Gupta
- Xi HangXHXi Hang
- Ruifu LiuRLRuifu Liu
- Armaan HasanAHArmaan Hasan
- Zhaoyang FengZFZhaoyang Feng
- 26 November 2015
- journal article
- Published by S. Karger AG in Neurodegenerative Diseases
- Vol. 16 (3-4) , 179-183
Abstract
Background: Levodopa-induced dyskinesia (LID) is a disabling complication of levodopa therapy in Parkinson's disease (PD) with no effective treatments. Fluctuations in levels of levodopa constitute a key risk factor of LID. There is a pressing need for the development of a simple animal model of LID. Several genetic and toxin-based models of PD in Caenorhabditis elegans have been described, which have advanced our understanding of PD pathophysiology. We aimed to study levodopa-induced changes in a Parkinson's disease model of C. elegans expressing human α-synuclein. Methods: We exposed the α-synuclein C. elegans to levodopa in continuous and alternating fashions. Automated behavioral analysis was then used to quantify changes in motor activity. Confocal microscopy was used next to quantify changes in dopamine receptor distribution and expression in motor neurons of live C. elegans. Results: Chronic exposure to levodopa led to hyperactivity of the α-synuclein C. elegans without meaningful increase in motor activity. There was also an increase in peripheral clustering and expression of dopamine receptors in motor neurons. Both of these changes were significantly higher with alternating, compared to continuous, exposure to levodopa. Conclusions: This is the first report of changes in motor and dopamine receptors induced by levodopa in C. elegans overexpressing human α-synuclein. We propose that these phenotypes represent a simple animal model of LID in C. elegans. Such a model holds the promise of enabling high-throughput screenings for potential therapeutic targets and drug candidates.Keywords
This publication has 24 references indexed in Scilit:
- The Neural Circuits and Synaptic Mechanisms Underlying Motor Initiation in C. elegansCell, 2011
- Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulationJournal of Neural Transmission, 2011
- Profiling a Caenorhabditis elegans behavioral parametric dataset with a supervised K-means clustering algorithm identifies genetic networks regulating locomotionJournal of Neuroscience Methods, 2011
- Enhanced striatal cholinergic neuronal activity mediatesl-DOPA–induced dyskinesia in parkinsonian miceProceedings of the National Academy of Sciences, 2010
- High‐throughput screening and small animal models, where are we?British Journal of Pharmacology, 2010
- Alpha-Synuclein Disrupted Dopamine Homeostasis Leads to Dopaminergic Neuron Degeneration in Caenorhabditis elegansPLOS ONE, 2010
- How do you treat motor complications in Parkinson's disease: Medicine, surgery, or both?Annals of Neurology, 2009
- C. elegans Model Identifies Genetic Modifiers of α-Synuclein Inclusion Formation During AgingPLOS Genetics, 2008
- The versatile worm: genetic and genomic resources for Caenorhabditis elegans researchNature Reviews Genetics, 2007
- Caenorhabditis elegans as a Model System for Parkinson’s DiseaseNeurodegenerative Diseases, 2007